--------------------------------------------------------------------------------

================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
LORUS THERAPEUTICS INC.
----------------------------------------------------------
(Exact name of the Registrant as specified in its charter)
ONTARIO, CANADA N/A
---------------------------------------- ------------------------------------
(State of incorporation or organization) (I.R.S. Employer Identification No.)
2 MERIDIAN ROAD, TORONTO, ONTARIO, CANADA M9W 4Z7
----------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
If this form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), please check the following box. [X]
If this form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), please check the following box. [ ]
Securities Act registration statement file number to which this form relates:
None
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
To be so Registered Each Class is to be Registered
-------------------------------- ------------------------------
Common Shares, without par value American Stock Exchange
Securities to be registered pursuant to Section 12(g) of the Act:
NONE
----------------
(Title of Class)
================================================================================
INFORMATION REQUIRED IN REGISTRATION STATEMENT
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
This Registrant Statement relates to the Common Shares, without par value, of
the registrant. A complete description of the Common Shares is set forth in the
Registration Statement on Form 20-F of the registrant, filed by the registrant
in December 1991 under the Securities Exchange Act of 1934. By this reference,
such description is incorporated herein and made a part hereof.
ITEM 2. EXHIBITS.
None.
--------------------------------------------------------------------------------
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has duly caused this Registration Statement to be signed
on its behalf by the undersigned, thereto duly authorized.
LORUS THERAPEUTICS INC.
By: /s/ Shane A. Ellis
------------------------------
Name: Shane A. Ellis
Title: V.P., Legal Affairs and
Corporate Secretary
Dated: February 16, 2004